BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 27906695)

  • 1. Metformin-Induced Generalized Fixed Drug Eruption With Cutaneous Hemophagocytosis.
    Ramírez-Bellver JL; Lopez J; Macias E; Fuertes L; Andres I; Alegria V; Gimeno I; Perez A; Perez Y; Requena L
    Am J Dermatopathol; 2017 Jun; 39(6):471-475. PubMed ID: 27906695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin-Induced Fixed-Drug Eruption Confirmed by Multiple Exposures.
    Steber CJ; Perkins SL; Harris KB
    Am J Case Rep; 2016 Apr; 17():231-4. PubMed ID: 27056044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical resemblance of widespread bullous fixed drug eruption to Stevens-Johnson syndrome or toxic epidermal necrolysis: report of two cases.
    Lin TK; Hsu MM; Lee JY
    J Formos Med Assoc; 2002 Aug; 101(8):572-6. PubMed ID: 12440088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peculiar unilateral fixed drug eruption of the breast.
    Li H; Wiederkehr M; Rao Bk; Samady JA; Gardner B; Lambert WC; Schwartz RA
    Int J Dermatol; 2002 Feb; 41(2):96-8. PubMed ID: 11982645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of Eyebrows and Eyelashes During Concomitant Treatment with Sitagliptin and Metformin.
    Succurro E; Palleria C; Ruffo M; Serra R; Arturi F; Gallelli L
    Curr Drug Saf; 2017; 12(1):10-12. PubMed ID: 27758711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophilic fixed drug eruption, a histopathologic variant or an expected finding?-A report of two cases and review of the literature.
    Theroux Z; Gardner J; Ortiz E; Kosik G; Junkins-Hopkins J
    J Cutan Pathol; 2023 Oct; 50(10):884-889. PubMed ID: 37403191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [One year persistence of metformin monotherapy versus metformin/sitagliptin fixed dose combination].
    Simonyi G; Ferenci T
    Orv Hetil; 2016 Apr; 157(16):618-22. PubMed ID: 27063429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lichen associated with metformin.
    Zaïem A; Sahnoun R; Badri T; Lakhoua G; Koubaa W; Kastalli S; Daghfous R; Lakhal M; El Aidli S
    Therapie; 2014; 69(3):253-4. PubMed ID: 24927507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent supravenous erythematous eruption: a rare local complication of intravenous 5-fluorouracil therapy.
    Pujol RM; Rocamora V; Lopez-Pousa A; Taberner R; Alomar A
    J Am Acad Dermatol; 1998 Nov; 39(5 Pt 2):839-42. PubMed ID: 9810911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psoriasiform drug eruption associated with metformin hydrochloride: a case report.
    Koca R; Altinyazar HC; Yenidünya S; Tekin NS
    Dermatol Online J; 2003 Aug; 9(3):11. PubMed ID: 12952758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ursodeoxycholic acid induced generalized fixed drug eruption.
    Ozkol HU; Calka O; Dulger AC; Bulut G
    Cutan Ocul Toxicol; 2014 Sep; 33(3):256-8. PubMed ID: 24147950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postcoital fixed drug eruption in a man sensitive to trimethoprim-sulphamethoxazole.
    Gruber F; Stasić A; Lenković M; Brajac I
    Clin Exp Dermatol; 1997 May; 22(3):144-5. PubMed ID: 9425695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histopathologic features of exanthematous drug eruptions of the macular and papular type.
    Naim M; Weyers W; Metze D
    Am J Dermatopathol; 2011 Oct; 33(7):695-704. PubMed ID: 21785331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophilic Fixed Drug Eruption.
    Waldman L; Reddy SB; Kassim A; Dettloff J; Reddy VB
    Am J Dermatopathol; 2015 Jul; 37(7):574-6. PubMed ID: 25072682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathological study of six types of adverse cutaneous drug reactions using granulysin expression.
    Weinborn M; Barbaud A; Truchetet F; Beurey P; Germain L; Cribier B
    Int J Dermatol; 2016 Nov; 55(11):1225-1233. PubMed ID: 27421110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What are these lesions that spread from the lips. Fixed drug eruption.
    Monroe JR
    JAAPA; 2010 Oct; 23(10):14. PubMed ID: 21128377
    [No Abstract]   [Full Text] [Related]  

  • 17. Dermatologic perivascular hemophagocytosis: a report of two cases.
    Draper NL; Morgan MB
    Am J Dermatopathol; 2007 Oct; 29(5):467-9. PubMed ID: 17890916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generalized fixed drug eruption to piperacillin/tazobactam and review of literature.
    Kornmehl H; Gorouhi F; Konia T; Fung MA; Tartar DM
    Dermatol Online J; 2018 Apr; 24(4):. PubMed ID: 29906010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute mucocutaneous methotrexate toxicity associated with interface dermatitis and numerous eosinophils.
    Ferguson NN; Asarch A; VanBeek M; Swick BL
    Am J Dermatopathol; 2013 Jun; 35(4):e63-6. PubMed ID: 23221488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed hypersensitivity reaction resulting in maculopapular-type eruption due to entecavir in the treatment of chronic hepatitis B.
    Kim JT; Jeong HW; Choi KH; Yoon TY; Sung N; Choi YK; Kim EH; Chae HB
    World J Gastroenterol; 2014 Nov; 20(42):15931-6. PubMed ID: 25400481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.